Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for Primary Prophylaxis of Taxotere/Cyclophosphamide-Induces Febrile Neutropenia
The Integrated Consent Model is being increasingly used internationally to improve patient
care. In this feasibility study we will explore whether the model is feasible in practice;
and whether it can be used to increase the number of physicians and patients who take part
in clinical trials, and address the critical issue around the optimal febrile neutropenia
prevention by randomizing eligible patients to either G-CSF or ciprofloxacin.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society